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Cockayne syndrome (CS) is a rare autosomal recessive disorder occurs in about 1 case per 2.77 million births [1]. It was first described by Cockayne in 
1936, and till now, around 150 cases have been reported in 
literature [2]. CS is associated with mutations in the gene CS 
Type A (CSA)/excision-repair cross-complementing protein 
(ERCC) 8 or CS Type B (CSB)/ERCC6 which provide 
instructions for repairing damaged DNA [3]. Clinically, three 
types of CS have been described in literature as classical, 
milder, and severe form depending on the time of presentation 
and severity of the clinical symptoms and final outcome 
[4]. The classical features of CS are progressive loss of 
subcutaneous fat and muscle, mental retardation, premature 
ageing, dwarfism, facial abnormalities, microcephaly, 
retinopathy, protruding neck, hearing loss, dental changes, 
large extremities, joints contracture, photosensitivity, dry skin, 
and hair [5]. Intracranial calcification and brain atrophy are 
seen in most of the individuals. Progression of syndrome leads 
to functional disability and bedridden in the 2nd decade of life 
and patients lastly die [6]. Early diagnosis is very important for 
patient management and proper parental genetic counseling. 
We present a case which is still worth important as a rare entity 
with its important clinical and radiological findings.
CASE REPORT
A 19-year-old male along with his father came in the 
neuromedicine outpatient department with complaints of 
progressive developmental delay, mental retardation, unable to 
walk and frequent falls when attempted, cachectic dwarfism in 
the form of short stature, loss of subcutaneous fat and muscles 
volume, microcephaly, and infrequent seizures. Dryness of skin 
and hair noted; however, no deformity of limbs was seen.
Eye and otorhinolaryngology examinations showed features 
of sensorineural hearing loss and visual field defects (retinitis 
pigmentosa). Ultrasonography of the whole abdomen was normal 
except loss of volume of intra-abdominal fat. The patient had a 
computed tomography scan of brain, done long ago, showing 
only soft basal ganglia calcification with subtle cortical sulci 
prominence. This time, the patient was advised for magnetic 
resonance imaging (MRI) of the brain and correlated for the 
same. MRI brain revealed severe diffuse cerebral cortical and 
periventricular white matter atrophy, cerebellar atrophy, widened 
all ventricles, thinned corpus callosum, bilateral basal ganglia 
calcifications, and diffuse atrophy of the brain stem (Figs. 1-3). 
Diffuse hyperintense T2-weighted/fluid-attenuated inversion 
recovery (FLAIR) change in cerebral white matter reflecting 
hypomyelination/demyelination was also noted (Fig. 4).
These typical MRI findings with early onset bilateral basal 
ganglia calcification noted in gradient sequence and T1-weighted 
sequences (Figs. 2 and 3) and classical clinical features (Fig. 5) 
supported the diagnosis of CS. The parents of the patient have 
been explained the prognosis of the disorder and advised for the 
general care of patient according to the symptoms.
DISCUSSION
CS is an autosomal recessive disorder with incidence around 1 case 
per 2.77 million births [1]. The basic pathology is deficient DNA 
repair mechanism due to mutation in gene CSA/ERCC8 and CSB/
ERCC6 located on the chromosomes 5 and 10, respectively [3]. 
Despite these, principle genes sensitivity of the patient fibroblasts 
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to ultraviolet C irradiation has been considered the diagnostic test 
of choice [7]. Important feature in CS is that in spite of deficient 
DNA repair, patients do not develop cancer. The CS consists of 
progressive neurodegeneration, mental retardation, progeria, 
ataxia, dwarfism, facial dysmorphism, microcephaly, abnormal 
photosensitivity, hearing loss, and joints contracture [5,8].
CS is a rare entity and around 150 cases have been reported 
in literature up till now [2]. Male-to-female ratio is 4:1. This 
syndrome does not get over until 4–5 years of age where 
growth and development almost appear normal and after that 
manifestation of progressive neurodegenerative changes become 
evident. Most of the patients live up to the 2nd decade and finally 
die due to severe respiratory and other infections [6].
Three types of CS described in the literature. Type I is 
the classical form and includes majority of the patients and 
present with normal fetal growth and onset of abnormality in 
the 1st 2 years of life. Peripheral and central nervous systems 
progressively degenerate until death in the 1st or 2nd decade of 
life due to severe neurological disorders. Cortical atrophy is not 
severe in this type. Type II is severe form present since birth. 
Neurological development is very poor after birth and death 
Figure 1: MRI T2W sagittal image showing diffuse atrophy of 
cerebrum, cerebellum, and brain stem. Ventricles are widely 
dilated secondary to brain atrophy, and bulging and thinned corpus 
callosum
Figure 2: MRI GRADIENT axial image showing bilateral basal 
ganglia calcification
Figure 3: MRI T2 FLAIR axial image showing diffuse cerebral 
atrophy and white matter hyperintensity representing demyelination/
hypomyelination of white matter
Figure 4: MRI T1W axial image showing diffuse cerebral atrophy, 
dilated ventricles, decreased volume of gray and white matter, and 
bilateral symmetrical hyperintense changes in basal ganglia due to 
soft calcification
Figure 5: A 19-year-old patient with “Cockayne syndrome” showing 
sunken eyes, protruding nose, reduced height (dwarfism), decreased 
subcutaneous fat and muscle volume, and inability to stand without 
support
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usually occurs around the age of seven [4]. This is also called 
as Cerebro-oculo-facio-skeletal syndrome [4]. Brain shows 
more severe damage including reduced myelination of white 
matter and more widespread calcification in the basal ganglia 
and cortex [9]. Type III is the milder form characterized by 
the late onset slow progression and these patients live up to 
adulthood [4].
Failure to thrive and neurological disorder are criteria for 
the diagnosis while photosensitivity, ophthalmic changes, 
sensorineural deafness, and dental disorder are other very 
common manifestation [10]. The neurologic changes are neuronal 
and myelin loss with calcium and iron deposition in the small 
vessels of the basal ganglia, cerebrum, and cerebellum. This 
neurodegeneration commonly presents as progressive mental 
retardation and ataxic gait. The other classical features are retinitis 
pigmentosa and photosensitive dermatosis. Neuroimaging 
including CT scan and MRI (T2 weighted and FLAIR) is the 
modality of choice for evaluation of brain.
MRI of the brain shows atrophy of the brain in supratentorial 
and infratentorial aspect along with hyperintense signal of 
the cerebral white matter on T2-weighted and FLAIR images 
representing hypomyelination/demyelination [11,12]. Early age 
basal ganglia calcification also prompts toward the syndrome 
along with cerebral and cerebellum calcification [10]. MRI results 
are compatible with diffuse cerebral white matter demyelination 
showing abnormal signal change.
The MRI of our patient also showed severe diffuse atrophy 
of cerebral, cerebellar, and brain stem causing marked dilatation 
of all ventricles and cerebrospinal fluid cisterns with cerebral 
white matter demyelination, bilateral basal ganglia calcification 
and clinical features of severe mental retardation, severe gait 
abnormality, and cachectic dwarfism. However, it was difficult 
to differentiate the CS from other white matter diseases in the 
absence of basal ganglia calcification. In the appropriate clinical 
setting, MRI features of brain atrophy, white matter changes and 
bilateral cerebral and basal ganglia calcification are sufficient to 
support the diagnosis.
No permanent cure of this disorder and patient treated 
according to their symptomatology. Genetic counseling of 
the parents is advised as the disorder has about 25% chance of 
penetration into any future offspring [10].
CONCLUSION
CS is rare disorder and diagnosis of CS can easily be made by the 
classical clinical manifestation along with typical brain changes 
in the radiological evaluation. MRI plays an important role in this 
regard showing demyelination of white matter, diffuse brain atrophy, 
and bilateral basal ganglia calcification as a hallmark changes in CS.
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